Work

Microbiome-targeted antibiotics provide no additional microbiologic or inflammatory benefit during cystic fibrosis pulmonary exacerbations: results from the CFMATTERS trial

Year: 2026

Type: article

Abstract: Gisli G Einarsson, Andrew J Lee, Zina Alfahl, Lauren Kerrigan, Joseph A Eustace, Sinéad Weldon, Barry J Plant, J Stuart Elborn, Clifford C Taggart, Marcus

Source: American Journal of Respiratory and Critical Care Medicine

DOI: 10.1093/ajrccm/aamag336

Authors: Gisli G Einarsson, Andrew J Lee, Zina Alfahl, Lauren Kerrigan, Joseph A Eustace, Sinéad Weldon, Barry J Plant, J Stuart Elborn, Clifford C Taggart, Marcus A Mall, Michael M Tunney

Institutions: Queen's University Belfast, University College Cork, Cork University Hospital, German Center for Lung Research, Charité - Universitätsmedizin Berlin

Language: English

Topic: Cystic Fibrosis Research Advances

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Funders: European Commission, Deutsche Forschungsgemeinschaft

Awards: Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified., G1768462002, G2920619578, G653298664, SFB 1449: Dynamische Hydrogele an Biogrenzflächen, G6769798452

OpenAlex ID: W7166507138

FWCI:

Cites:

Cited by:

Related to: